July 22nd 2025
The rapidly increasing prescriptions for expensive specialty medications, rather than their price growth, are the primary driver of escalating dermatology Medicare Part D expenditures, necessitating policies that balance innovation, access, and affordability.
Impact of Payment Reform on Chemotherapy at the End of Life
Payment reform may be used to better align appropriate financial incentives with better quality of care.
Read More